191 related articles for article (PubMed ID: 34625422)
1. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
2. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
[TBL] [Abstract][Full Text] [Related]
3.
Fang Z; Wang Y; Wang Z; Xu M; Ren S; Yang D; Hong M; Xie W
Cancer Res; 2020 Oct; 80(20):4399-4413. PubMed ID: 32826278
[TBL] [Abstract][Full Text] [Related]
4. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
5. PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
Itsumi M; Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
J Mol Endocrinol; 2014 Aug; 53(1):31-41. PubMed ID: 24780839
[TBL] [Abstract][Full Text] [Related]
6. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.
Sharma A; Yeow WS; Ertel A; Coleman I; Clegg N; Thangavel C; Morrissey C; Zhang X; Comstock CE; Witkiewicz AK; Gomella L; Knudsen ES; Nelson PS; Knudsen KE
J Clin Invest; 2010 Dec; 120(12):4478-92. PubMed ID: 21099110
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of RB status on E2F1 reprogramming in human cancer.
McNair C; Xu K; Mandigo AC; Benelli M; Leiby B; Rodrigues D; Lindberg J; Gronberg H; Crespo M; De Laere B; Dirix L; Visakorpi T; Li F; Feng FY; de Bono J; Demichelis F; Rubin MA; Brown M; Knudsen KE
J Clin Invest; 2018 Jan; 128(1):341-358. PubMed ID: 29202480
[TBL] [Abstract][Full Text] [Related]
8. PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
Liu B; Li L; Yang G; Geng C; Luo Y; Wu W; Manyam GC; Korentzelos D; Park S; Tang Z; Wu C; Dong Z; Sigouros M; Sboner A; Beltran H; Chen Y; Corn PG; Tetzlaff MT; Troncoso P; Broom B; Thompson TC
Clin Cancer Res; 2019 Nov; 25(22):6839-6851. PubMed ID: 31439587
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.
Yeh S; Miyamoto H; Nishimura K; Kang H; Ludlow J; Hsiao P; Wang C; Su C; Chang C
Biochem Biophys Res Commun; 1998 Jul; 248(2):361-7. PubMed ID: 9675141
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
11. RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.
Mandigo AC; Yuan W; Xu K; Gallagher P; Pang A; Guan YF; Shafi AA; Thangavel C; Sheehan B; Bogdan D; Paschalis A; McCann JJ; Laufer TS; Gordon N; Vasilevskaya IA; Dylgjeri E; Chand SN; Schiewer MJ; Domingo-Domenech J; Den RB; Holst J; McCue PA; de Bono JS; McNair C; Knudsen KE
Cancer Discov; 2021 Sep; 11(9):2334-2353. PubMed ID: 33879449
[TBL] [Abstract][Full Text] [Related]
12. The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.
Hossain S; Iwasa H; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891515
[TBL] [Abstract][Full Text] [Related]
13. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
[TBL] [Abstract][Full Text] [Related]
14. ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer.
Han D; Chen S; Han W; Gao S; Owiredu JN; Li M; Balk SP; He HH; Cai C
Cancer Res; 2019 Oct; 79(20):5260-5271. PubMed ID: 31444154
[TBL] [Abstract][Full Text] [Related]
15. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract][Full Text] [Related]
16. Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
Udayakumar TS; Hachem P; Ahmed MM; Agrawal S; Pollack A
Mol Cancer Res; 2008 Nov; 6(11):1742-54. PubMed ID: 19010821
[TBL] [Abstract][Full Text] [Related]
17. CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.
Bargiela-Iparraguirre J; Prado-Marchal L; Fernandez-Fuente M; Gutierrez-González A; Moreno-Rubio J; Muñoz-Fernandez M; Sereno M; Sanchez-Prieto R; Perona R; Sanchez-Perez I
Sci Rep; 2016 Feb; 6():21519. PubMed ID: 26867682
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
[TBL] [Abstract][Full Text] [Related]
19. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
20. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]